HUE051296T2 - Benzoxazinon-származékok bõrbetegségek kezelésére - Google Patents
Benzoxazinon-származékok bõrbetegségek kezeléséreInfo
- Publication number
- HUE051296T2 HUE051296T2 HUE15740572A HUE15740572A HUE051296T2 HU E051296 T2 HUE051296 T2 HU E051296T2 HU E15740572 A HUE15740572 A HU E15740572A HU E15740572 A HUE15740572 A HU E15740572A HU E051296 T2 HUE051296 T2 HU E051296T2
- Authority
- HU
- Hungary
- Prior art keywords
- treatment
- skin diseases
- benzoxazinone derivatives
- benzoxazinone
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/539—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more oxygen atoms in the same ring, e.g. dioxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
- C07D265/22—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1430003 | 2014-01-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE051296T2 true HUE051296T2 (hu) | 2021-03-01 |
Family
ID=53681747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE15740572A HUE051296T2 (hu) | 2014-01-23 | 2015-01-22 | Benzoxazinon-származékok bõrbetegségek kezelésére |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US9695194B2 (enExample) |
| EP (1) | EP3097085B1 (enExample) |
| JP (1) | JP6448651B2 (enExample) |
| CN (1) | CN106132941B (enExample) |
| AU (1) | AU2015209761B2 (enExample) |
| CA (1) | CA2934025C (enExample) |
| CY (1) | CY1123477T1 (enExample) |
| DK (1) | DK3097085T3 (enExample) |
| ES (1) | ES2820868T3 (enExample) |
| HR (1) | HRP20201500T1 (enExample) |
| HU (1) | HUE051296T2 (enExample) |
| LT (1) | LT3097085T (enExample) |
| PL (1) | PL3097085T3 (enExample) |
| PT (1) | PT3097085T (enExample) |
| RS (1) | RS60830B1 (enExample) |
| SI (1) | SI3097085T1 (enExample) |
| SM (1) | SMT202000557T1 (enExample) |
| WO (1) | WO2015112081A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2934025C (en) * | 2014-01-23 | 2022-06-07 | Fredrik Wagberg | Benzoxazinone derivatives for treatment of skin diseases |
| RU2720996C2 (ru) * | 2015-05-13 | 2020-05-15 | Нихон Нохияку Ко., Лтд. | Соединение антранилата кислоты, его соль, фунгицид, включающий это соединение, и способ его применения |
| WO2017123401A1 (en) * | 2016-01-13 | 2017-07-20 | Children's Hospital Medical Center | Compositions and methods for treating allergic inflammatory conditions |
| JP2020527357A (ja) | 2017-06-16 | 2020-09-10 | アジトラ インコーポレーテッド | Ｌｅｋｔｉ発現組換え微生物を用いたネザートン症候群の処置のための組成物および方法 |
| US20200040103A1 (en) | 2018-03-14 | 2020-02-06 | Genentech, Inc. | Anti-klk5 antibodies and methods of use |
| EP3781588B1 (en) | 2018-04-20 | 2024-10-30 | Children's Hospital Medical Center | Blood biomarker for eosinophilic gastrointestinal disorders |
| GB201809378D0 (en) | 2018-06-07 | 2018-07-25 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| US12297501B2 (en) | 2019-02-25 | 2025-05-13 | Children's Hospital Medical Center | Methods for diagnosing and treating eosinophilic gastritis |
| US12312414B2 (en) | 2019-09-18 | 2025-05-27 | Genentech, Inc. | Anti-KLK7 antibodies, anti-KLK5 antibodies, multispecific anti-KLK5/KLK7 antibodies, and methods of use |
| WO2021067335A1 (en) | 2019-10-01 | 2021-04-08 | Molecular Skin Therapeutics, Inc. | Benzoxazinone compounds as klk5/7 dual inhibitors |
| GB202001447D0 (en) * | 2020-02-03 | 2020-03-18 | Ucb Biopharma Sprl | Antibodies |
| BR102020009679A2 (pt) | 2020-05-14 | 2021-11-23 | Fundação Universidade Federal Do Abc - Ufabc | Anticorpos recombinantes humanos para inibição da calicreína tecidual humana 7 (klk7) e uso em doenças relacionadas ao processo de descamação da pele |
| TW202304890A (zh) * | 2021-04-14 | 2023-02-01 | 美商百歐克斯製藥公司 | Klk5雙環雜芳香族抑制劑 |
| US20240180915A1 (en) | 2021-06-01 | 2024-06-06 | Sixera Pharma Ab | Oil-in-water emulsion of 6-ethoxy-7-methoxy-2-(2-methylsulfanylphenyl)-3,l-benzoxazin-4-one |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB115399A (en) * | 1917-03-28 | 1918-04-29 | Reginald Guley Lewis | Improved Delivery mechanism for Coin-freed Apparatus and the like. |
| GB1153994A (en) | 1965-07-21 | 1969-06-04 | Aspro Nicholas Ltd | Hydroxyphenyl Anthranilic Acid Derivatives Capable of Absorbing 'Ultra-Violet Light and Compositions containing them |
| WO1999048878A1 (en) * | 1998-03-24 | 1999-09-30 | Novo Nordisk A/S | Heterocyclic compounds regulating clotting |
| PT1631295E (pt) | 2003-06-06 | 2010-05-24 | Arexis Ab | Uso de compostos heterocíclicos condensados como inibidores de scce para o tratamento de doenças da pele |
| TWI419884B (zh) * | 2010-06-24 | 2013-12-21 | Univ Chang Gung | 苯并雜氧嗪酮衍生物，其製備方法以及包含有此等衍生物的藥學組成物 |
| CA2934025C (en) * | 2014-01-23 | 2022-06-07 | Fredrik Wagberg | Benzoxazinone derivatives for treatment of skin diseases |
-
2015
- 2015-01-22 CA CA2934025A patent/CA2934025C/en active Active
- 2015-01-22 PT PT157405721T patent/PT3097085T/pt unknown
- 2015-01-22 WO PCT/SE2015/050062 patent/WO2015112081A1/en not_active Ceased
- 2015-01-22 ES ES15740572T patent/ES2820868T3/es active Active
- 2015-01-22 JP JP2016544672A patent/JP6448651B2/ja active Active
- 2015-01-22 LT LTEP15740572.1T patent/LT3097085T/lt unknown
- 2015-01-22 PL PL15740572T patent/PL3097085T3/pl unknown
- 2015-01-22 EP EP15740572.1A patent/EP3097085B1/en active Active
- 2015-01-22 DK DK15740572.1T patent/DK3097085T3/da active
- 2015-01-22 HU HUE15740572A patent/HUE051296T2/hu unknown
- 2015-01-22 CN CN201580005383.4A patent/CN106132941B/zh active Active
- 2015-01-22 US US15/113,750 patent/US9695194B2/en active Active
- 2015-01-22 RS RS20201128A patent/RS60830B1/sr unknown
- 2015-01-22 SI SI201531393T patent/SI3097085T1/sl unknown
- 2015-01-22 SM SM20200557T patent/SMT202000557T1/it unknown
- 2015-01-22 AU AU2015209761A patent/AU2015209761B2/en active Active
- 2015-01-22 HR HRP20201500TT patent/HRP20201500T1/hr unknown
-
2017
- 2017-06-05 US US15/614,462 patent/US10072024B2/en active Active
-
2020
- 2020-10-20 CY CY20201100988T patent/CY1123477T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015209761A1 (en) | 2016-07-07 |
| DK3097085T3 (da) | 2020-10-26 |
| US20170267692A1 (en) | 2017-09-21 |
| HRP20201500T1 (hr) | 2020-12-25 |
| RS60830B1 (sr) | 2020-10-30 |
| EP3097085B1 (en) | 2020-07-29 |
| EP3097085A4 (en) | 2017-08-09 |
| PT3097085T (pt) | 2020-10-08 |
| AU2015209761B2 (en) | 2018-11-29 |
| CA2934025C (en) | 2022-06-07 |
| ES2820868T3 (es) | 2021-04-22 |
| CN106132941B (zh) | 2018-04-06 |
| US10072024B2 (en) | 2018-09-11 |
| PL3097085T3 (pl) | 2021-01-11 |
| SMT202000557T1 (it) | 2020-11-10 |
| LT3097085T (lt) | 2020-10-12 |
| WO2015112081A1 (en) | 2015-07-30 |
| CY1123477T1 (el) | 2022-03-24 |
| JP2017503798A (ja) | 2017-02-02 |
| US9695194B2 (en) | 2017-07-04 |
| EP3097085A1 (en) | 2016-11-30 |
| CA2934025A1 (en) | 2015-07-30 |
| CN106132941A (zh) | 2016-11-16 |
| JP6448651B2 (ja) | 2019-01-09 |
| SI3097085T1 (sl) | 2020-11-30 |
| US20170002021A1 (en) | 2017-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE060711T2 (hu) | Makrociklusos vegyületek betegségek kezelésére | |
| HUE051296T2 (hu) | Benzoxazinon-származékok bõrbetegségek kezelésére | |
| DK3212233T3 (da) | Kombinationsterapi til behandling af sygdom | |
| IL249065A0 (en) | Combination therapies for the treatment of cancer | |
| PL3169328T3 (pl) | Pochodne chinoliny do leczenia chorób zapalnych | |
| LT3556775T (lt) | Anti-lag-3 antikūnai, skirti hematologinių piktybinių susirgimų gydymui | |
| LT3206715T (lt) | Kanabidiolio naudojimas tuberozinės sklerozės komplekso gydymui | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| PL3265053T3 (pl) | Sposoby leczenia skóry | |
| HUE059694T2 (hu) | Készítmény rák kezelésére | |
| LT3390390T (lt) | Bipirazolilo dariniai, tinkami naudoti autoimuninių ligų gydymui | |
| SI3157534T1 (sl) | Inhibitorji acetilholinesteraze za zdravljenje dermatoloških obolenj | |
| EP3215219C0 (en) | SKIN TREATMENT SYSTEM | |
| IL249502B (en) | New therapeutic uses of benzylideneguanidine derivatives for the treatment of diseases caused by structurally abnormal proteins | |
| HUE060517T2 (hu) | Immunhiányos betegség kezelésére szolgáló eljárások | |
| HUE053443T2 (hu) | Heteroaril vegyületek szembetegségek kezelésére | |
| LT3119384T (lt) | Intrahepatinių cholestazinių ligų gydymas | |
| HUE053648T2 (hu) | Gyógyászati kombinációk rák kezelésére | |
| KR20180084983A (ko) | 암의 치료를 위한 피리미도-피리미다지논의 용도 | |
| HUE070257T2 (hu) | Vegyületek a lipofuscinhoz kapcsolódó betegségek kezelésére | |
| IL259381B (en) | Mirabegron for the treatment of retinal diseases | |
| PL3302499T3 (pl) | Leczenie chorób mitochondrialnych | |
| HUE063820T2 (hu) | Módszerek kardiovaszkuláris betegségek kezelésére | |
| DK3182980T3 (da) | Behandling af glykosyleringsmangelsygdomme | |
| IL263076B (en) | Treatment of skin lesions |